Substance/Medication-Induced Obsessive-Compulsive and Related Disorder 259
When recording the name of the disorder, the comorbid substance use disorder (if any) is
listed first, followed by the wo rd “with,” followed by the name  of the substance-induced ob-
sessive-compulsive and related diso rder, followed by the specification of onset (i.e., onset dur-
ing intoxication, onset during withdrawal, with  onset after medication use). For example, in
the case of repetitive behaviors occurring during  intoxication in a man with a severe cocaine
use disorder, the diagnosis is F14.288 severe co caine use disorder with cocaine-induced obses-
sive-compulsive and related disorder, with onse t during intoxication. A separate diagnosis of
the comorbid severe cocaine use disorder is not given. If the substance-induced obsessive-
compulsive and related disorder occurs without a comorbid substance use disorder (e.g., after
a one-time heavy use of the substance), no accompanying substance use disorder is noted (e.g.,
F15.988 amphetamine-induced obsessive-compulsive  and related disorder, with onset during
intoxication). When more than on e substance is judged to play a significant role in the devel-
opment of the obsessive-compulsive and relate d disorder, each should be listed separately.
Diagnostic Features
The essential features of substance/medicati on-induced obsessive-co mpulsive and related
disorder are prominent symptoms of an obsessive-compulsive  and related disorder (Criterion
A) that are judged to be attributable to the e ffects of a substance (e.g., drug of abuse, medica-
tion). The obsessive-compulsive and related disorder symptoms must have developed during
or soon after substance intoxication or withdraw al or after exposure to a medication or toxin,